Nitric oxide releasing steroids
    8.
    发明授权
    Nitric oxide releasing steroids 有权
    一氧化氮释放类固醇

    公开(公告)号:US08933062B2

    公开(公告)日:2015-01-13

    申请号:US12525970

    申请日:2008-01-28

    CPC分类号: C07J41/005

    摘要: The invention relates to nitrooxyderivative of corticosteroids of general formula (I) and pharmaceutically acceptable salts or stereoisomers thereof R—(Z)a—Rx  (I) wherein R is the corticosteroid residue of formula (II): wherein: R1 is OH, R2—CH3, or R1 and R2 are taken together to form a group of formula (III) R3 is Cl or F; R4 is H or F; wherein R1, R2, R3 and R4 can be linked to the correspondent carbon atoms of the steroidal structure in position α or β; with the proviso that: when R1 and R2 are the group of formula (III) then R3 is F and R4 is H or F; The compounds are useful in the treatment of respiratory diseases, inflammatory diseases, dermatological diseases and ocular diseases.

    摘要翻译: 本发明涉及通式(I)的糖皮质激素及其药学上可接受的盐或立体异构体的硝基氧基衍生物R-(Z)a-Rx(I)其中R是式(II)的皮质类固醇残基:其中:R1是OH,R2 -CH 3或R 1和R 2一起形成式(III)的基团,R 3为Cl或F; R4是H或F; 其中R 1,R 2,R 3和R 4可以连接到甾族结构在位置α或bgr中的相应碳原子。 条件是:当R 1和R 2是式(III)的基团时,R 3是F且R 4是H或F; 该化合物可用于治疗呼吸系统疾病,炎性疾病,皮肤病和眼部疾病。